Regulation of telomerase activity and cell cycle of K562 cells by oridonin

Yaoxue Xuebao

Volumn 39, Issue 11, 2004, Pages 865-868

  Li, Rui Fang ^a   Wang, Qing Duan ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Antitumor agent; K562 cells; Oridonin; Telomerase

Indexed keywords

MYC PROTEIN; ORIDONIN; TELOMERASE;

ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL STRAIN K 562; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METAPHASE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; DITERPENES; DITERPENES, KAURANE; DNA-BINDING PROTEINS; HUMANS; K562 CELLS; PLANTS, MEDICINAL; PROTO-ONCOGENE PROTEINS C-MYC; RABDOSIA; TELOMERASE;

EID: 13244253835     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Zhang TM. A new anticancer drug - oridonin [J]. Sci Bull, 1978,23(1):53-54.
2. Wang MY, Ye QX, Li GD, et al. The experimental study of oridonin in combination with VCR and DDP [J]. J Henan Med Univ, 1987,22 (3):211-216.
3. Guo JJ, Pan XL, Feng CW, et al. Effects of oridonin on inducing the multi-drug resistant cell line K562/A02 to apotosis and reversing their multi-drug resistance [J]. J Anhui Tradit Chin Med Coll, 2000,19(3):34-36.
4. Hoos A, Hcpp HH, Kaul S, et al. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer [J]. Int J Cancer, 1998,79(1): 8-12.
5. Xie WZ, Lin MF. Inhibition effect of homoharringtonine on telomerase activity of K562 cells [J]. J Pract Oncol, 2001,16(4):240-242.
6. Latil A, Vidaud D, ValeriA, et al. HTERT expression correlates with myc over expression in human prostate cancer [J]. Int J Cancer, 2000,89(2):172-176.
7. Lin Y, Zeng X, Xie WF, et al. Human telomerase reserve transcriptase (htert) activity correlates with c-myc expression and regulation in hepatoma cell lines [J]. Cancer Prevent Treat Res, 2002,29 (5):359-361.
8. Liu CJ, Zhao ZH. The progress of research about oridonin [J]. Chin Pharm J, 1998, 33(10):577-581.
9. Zhang LP, Cao Q. The effect of AS-ODN targeting against telomerase RNA on proliferation in K562 cells [J]. Chin J Clin Oncol, 2002,29(9):622-624.
10. Li DJ, Zhang, YZ, Meng FK, et al. Regulative function of extracelluar regulated protein kinases and telomerase in apoptosis of hepatocarcinomatous and leukemic cell lines [J]. J Exp Hematol, 2002,10 (4):294-298.
11. Zhang JX, Zhang ZK, Sheng HP, et al. Telomerase activity is not related to apoptosis in leukemic cell lines [J]. Life Sci, 2000,66(18):1713-1723.